Bryant Fong - 22 Aug 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADMA	Common Stock	Sale	$5,544,737	-1,433,304	-100%	$3.87	0	22 Aug 2023	See footnote	F1, F2
holding	ADMA	Common Stock						59,901	22 Aug 2023	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Reflects the weighted average price of sales on August 22, 2023. The shares were sold in multiple transactions at prices ranging from $3.81 to $3.99, inclusive.
F2	Represents shares sold by Biomark Capital Fund ("Biomark Capital"). Mr. Fong is a Managing Director and General Partner at Biomark Capital and may have been deemed the beneficial owner of such shares.
F3	Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 34,086 shares of common stock owned by the reporting person.